BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Calendar//CN-US Event Research//ZH
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Calendar
X-WR-CALDESC:Market-moving event research, reminders and post-event review.
BEGIN:VEVENT
UID:evt-aacr-d3-2026-drug-discovery-development@catalyst-calendar.local
DTSTAMP:20260720T200531Z
DTSTART:20260721T130000Z
DTEND:20260721T133000Z
SUMMARY:AACR D3 2026肿瘤药物发现与开发会议窗口
DESCRIPTION:首届AACR Drug Discovery and Development会议将于2026-07-21至2026-07-24在波士顿举行，聚焦肿瘤药物发现、转化研究和开发管线，可能影响ADC、双抗、放射性药物、AI药物发现和早期肿瘤资产主题。\\nImpact score: 64\\nExpected: 重点观察早期肿瘤技术平台、biotech presentation和跨药企合作线索，作为下半年授权并购和早期管线估值的发现窗口。\\nAffected: XBI(etf\, mixed\, score 62)\; IBB(etf\, mixed\, score 56)\; BNTX(theme\, mixed\, score 52)\; MRK(theme\, mixed\, score 50)\\nSources: AACR D3 2026 official page: https://www.aacr.org/meeting/aacr-d3-2026/\\nAACR D3 program: https://www.aacr.org/meeting/aacr-d3-2026/program/\\nAACR D3 blog: https://www.aacr.org/blog/2026/05/29/aacr-d3-the-global-one-stop-conference-for-drug-discovery-and-development/\\nInformation only. Not investment advice.
URL:https://0.0.0.0:3000/?event=evt-aacr-d3-2026-drug-discovery-development
CATEGORIES:conference\,ETF\,AACR\,D3\,drug discovery\,oncology
SEQUENCE:0
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:Review catalyst preview: AACR D3 2026肿瘤药物发现与开发会议窗口
END:VALARM
BEGIN:VALARM
TRIGGER:PT24H
ACTION:DISPLAY
DESCRIPTION:Complete post-event review: AACR D3 2026肿瘤药物发现与开发会议窗口
END:VALARM
END:VEVENT
END:VCALENDAR